Open AccessFeasibility of capecitabine monotherapy in a taxane refractory metastatic breast cancer patient: A rural cancer hospital experience
Author(s) -
V. Tiwari,
Piyush Kumar Shukla,
Gourav Gupta
Publication year - 2013
Publication title -
oncology, gastroenterology and hepatology reports
Language(s) - English
Resource type - Journals
eISSN - 2348-3113
pISSN - 2278-8921
DOI - 10.5530/ogh.2013.1.7
Subject(s) - capecitabine , medicine , metastatic breast cancer , taxane , cancer , breast cancer , quality of life (healthcare) , chemotherapy , patient experience , disease , oncology , intensive care medicine , refractory (planetary science) , nursing , health care , colorectal cancer , economics , economic growth , physics , astrobiology
To manage a metastatic cancer patient in a rural setting is a daunting task owing to the lack of resources
and infrastructure. Intravenous chemotherapy (CT), with its debilitating side effects often causes a decrease in
the quality of life (QOL) of the patient. When the treatment is of palliative intent, efforts should be made to
provide maximum symptom relief to the patient striking a balance between the patient’s wishes and a sound
scientific rationale. We describe our experience with a patient with extensively metastatic breast cancer treated
in our rural center with single agent oral capecitabine, without development of any severe toxicity and with a
significant improvement in disease process and patient’s performance status (PS